User:Cristina Malagelada Grau: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 30: Line 30:
<biblio>
<biblio>
#Paper1 pmid=20089925
#Paper1 pmid=20089925
#Paper2 pmid=13718526
#Paper2 pmid=19741297
#Paper3 pmid=19555759
#Paper4 pmid=19165601
#Paper5 pmid=19118169
#Paper6 pmid=19118169
#Paper7 pmid=19118169
#Paper8 pmid=16380382
#Paper9 pmid=16187218
#Paper10 pmid=16137564
#Paper11 pmid=15787690
#Paper12 pmid=15322300
 
// leave a comment about a paper here
// leave a comment about a paper here
#Book1 isbn=0879697164
#Book1 isbn=0879697164

Revision as of 06:17, 16 July 2010

I am a new member of OpenWetWare!

Contact Info

Cristina Malagelada Grau
  • Cristina Malagelada Grau, PhD. Ramón y Cajal investigator.
  • Contact information: Department of Pharmacology, University of Barcelona
  • Address: Casanova 143 main floor Barcelona 08036, Catalonia, Spain
  • Phone: +34-934024526
  • E-mail: cristina.malagelada@ub.edu

Education

  • 2010-2015, Ramon y Cajal investigator, Universitat de Barcelona , Barcelona , Catalonia, (Spain)
  • 2008-2010,Associate research scientist, Columbia University New York (NY) (USA)
  • 2004-2008, Postdoctoral research scientist, Columbia University New York (NY) (USA)
  • 2003-2004, Postdoctoral fellowship, Mount Sinai School of Medicine, New York (NY) (USA)
  • 2003, PhD,Biochemistry, Universitat Autònoma de Barcelona, Catalonia (Spain)
  • 2000, MS, Neurochemistry, Universitat Autònoma de Barcelona, Catalonia (Spain)
  • 1998, BS, Biochemistry, Universitat Autònoma de Barcelona, Catalonia (Spain)

Research interests

  1. Parkinson's disease
  2. Neurodegeneration
  3. Neurogenesis

Publications

  1. Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, and Greene LA. Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J Neurosci. 2010 Jan 20;30(3):1166-75. DOI:10.1523/JNEUROSCI.3944-09.2010 | PubMed ID:20089925 | HubMed [Paper1]
  2. Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, Backs T, Bassel-Duby R, Olson EN, Anderson ME, and Tabas I. Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest. 2009 Oct;119(10):2925-41. DOI:10.1172/JCI38857 | PubMed ID:19741297 | HubMed [Paper2]
  3. Badiola N, Malagelada C, Llecha N, Hidalgo J, Comella JX, Sabriá J, and Rodríguez-Alvarez J. Activation of caspase-8 by tumour necrosis factor receptor 1 is necessary for caspase-3 activation and apoptosis in oxygen-glucose deprived cultured cortical cells. Neurobiol Dis. 2009 Sep;35(3):438-47. DOI:10.1016/j.nbd.2009.06.005 | PubMed ID:19555759 | HubMed [Paper3]
  4. Levy OA, Malagelada C, and Greene LA. Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps. Apoptosis. 2009 Apr;14(4):478-500. DOI:10.1007/s10495-008-0309-3 | PubMed ID:19165601 | HubMed [Paper4]
  5. Malagelada C, Jin ZH, and Greene LA. RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J Neurosci. 2008 Dec 31;28(53):14363-71. DOI:10.1523/JNEUROSCI.3928-08.2008 | PubMed ID:19118169 | HubMed [Paper5]
  6. Malagelada C, Jin ZH, and Greene LA. RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J Neurosci. 2008 Dec 31;28(53):14363-71. DOI:10.1523/JNEUROSCI.3928-08.2008 | PubMed ID:19118169 | HubMed [Paper6]
  7. Malagelada C, Jin ZH, and Greene LA. RTP801 is induced in Parkinson's disease and mediates neuron death by inhibiting Akt phosphorylation/activation. J Neurosci. 2008 Dec 31;28(53):14363-71. DOI:10.1523/JNEUROSCI.3928-08.2008 | PubMed ID:19118169 | HubMed [Paper7]
  8. Xifró X, Falluel-Morel A, Miñano A, Aubert N, Fadó R, Malagelada C, Vaudry D, Vaudry H, Gonzalez B, and Rodríguez-Alvarez J. N-methyl-D-aspartate blocks activation of JNK and mitochondrial apoptotic pathway induced by potassium deprivation in cerebellar granule cells. J Biol Chem. 2006 Mar 10;281(10):6801-12. DOI:10.1074/jbc.M504571200 | PubMed ID:16380382 | HubMed [Paper8]
  9. Biswas SC, Ryu E, Park C, Malagelada C, and Greene LA. Puma and p53 play required roles in death evoked in a cellular model of Parkinson disease. Neurochem Res. 2005 Jun-Jul;30(6-7):839-45. DOI:10.1007/s11064-005-6877-5 | PubMed ID:16187218 | HubMed [Paper9]
  10. Malagelada C, Xifró X, Miñano A, Sabriá J, and Rodríguez-Alvarez J. Contribution of caspase-mediated apoptosis to the cell death caused by oxygen-glucose deprivation in cortical cell cultures. Neurobiol Dis. 2005 Oct;20(1):27-37. DOI:10.1016/j.nbd.2005.01.028 | PubMed ID:16137564 | HubMed [Paper10]
  11. Xifro X, Malagelada C, Miñano A, and Rodríguez-Alvarez J. Brief exposure to NMDA produces long-term protection of cerebellar granule cells from apoptosis. Eur J Neurosci. 2005 Feb;21(4):827-40. DOI:10.1111/j.1460-9568.2005.03935.x | PubMed ID:15787690 | HubMed [Paper11]
  12. Malagelada C, Xifró X, Badiola N, Sabrià J, and Rodríguez-Alvarez J. Histamine H2-receptor antagonist ranitidine protects against neural death induced by oxygen-glucose deprivation. Stroke. 2004 Oct;35(10):2396-401. DOI:10.1161/01.STR.0000141160.66818.24 | PubMed ID:15322300 | HubMed [Paper12]

    leave a comment about a paper here

  13. ISBN:0879697164 [Book1]

All Medline abstracts: PubMed | HubMed

Useful links